| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 09/28/2006 | US20060217537 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via ketene using diazo compounds and carbon-isotope monoxide |
| 09/28/2006 | US20060217363 Methods and therapeutic combinations for the treatment of hypercholesterolemia and xanthoma using sterol absorption inhibitors |
| 09/20/2006 | EP1702916A1 DPP-IV inhibitors |
| 09/14/2006 | WO2006095020A1 Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 09/14/2006 | DE102005010770A1 Producing 1,4-diphenylazetidinone derivatives useful as cholesterol resorption inhibitors from protected beta-substituted amino amides comprises using a quaternary phosphonium salt catalyst |
| 09/14/2006 | CA2600674A1 Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 09/13/2006 | EP1699760A2 Anti-hypercholesterolemic compounds |
| 09/13/2006 | EP1699759A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 09/13/2006 | EP1699758A1 Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity |
| 09/13/2006 | EP1196431B1 A substantially crystalline form of melagatran |
| 09/12/2006 | US7105537 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis |
| 09/08/2006 | WO2006093352A1 Compound having cyclic structure and use thereof |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | CN1273467C Beta-lactam compounds, process for producing the same and serum cholesterol-lowering agents containing the same |
| 09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 08/31/2006 | WO2006090153A1 Process for preparing protected amiidines |
| 08/31/2006 | CA2598496A1 Process for preparing protected amiidines |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1345924B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 08/30/2006 | CN1826344A (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 08/23/2006 | EP1692103A1 Process for converting heterocyclic ketones to amido-substituted heterocycles |
| 08/22/2006 | US7094777 5-HT2A receptor ligands |
| 08/16/2006 | CN1269807C Aryl substituted piperazine for curing benign prostatauxe |
| 08/10/2006 | WO2006012310A3 Carbazole derivatives for treating polycystic kidney disease |
| 08/10/2006 | US20060178312 Process for the production of melagatran |
| 08/09/2006 | EP1687287A1 A novel process for ezetimibe intermediate |
| 08/09/2006 | CN1816544A Immunosuppressant compounds and compositions |
| 08/08/2006 | US7087604 Antiarthritic agents;multiple sclerosis; anticholesterol agents; cardiovascular disorders |
| 08/08/2006 | US7087594 Alkyl ether derivatives or salts thereof |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685102A1 Melanocortin receptor agonists |
| 08/02/2006 | EP1685100A1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | CN1812790A 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor |
| 07/27/2006 | WO2006077026A1 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-i) inhibitors for the treatment of neurological and neuropsychiatry disorders |
| 07/27/2006 | WO2005054185A8 Azetidine derivatives, method for producing said derivatives and use thereof |
| 07/27/2006 | US20060167284 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 07/27/2006 | US20060167249 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 07/27/2006 | US20060167244 Polymerisation inhibitor |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060165648 Compounds, compositions, and methods for controlling biofilms |
| 07/27/2006 | CA2601326A1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1(glyt-i) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 07/26/2006 | EP1682499A1 4-biarylyl-1-phenylazetidin-2-ones |
| 07/26/2006 | EP1682120A2 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 07/26/2006 | EP1682117A1 2-azetidinones as anti-hypercholesterolemic agents |
| 07/26/2006 | EP0681568B1 Process for preparation of taxane derivatives and beta-lactam intermediates therefor |
| 07/26/2006 | CN1266148C Method for producing 2-azetidinone derivative |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/20/2006 | US20060161005 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
| 07/20/2006 | US20060160788 such as Rac-(2-isopropoxy-5-methanesulfonyl-phenyl)-[3-(4-trifluoromethyl-phenoxy)-pyrrolidin-1-yl]-methanone, having good glycine transporter inhibitory activity and useful for the treatment of nervous system disorders such as schizophrenia, cognitive impairment and Alzheimer's disease |
| 07/20/2006 | US20060160787 for example 1-(methylthio)-3-methoxy-4-(2-fluorophenyl)azetidin-2-one; induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation |
| 07/20/2006 | US20060160785 Ezetimibe polymorphs |
| 07/19/2006 | CN1805926A Process for the preparation of trans-isomers of diphenylazetidinone derivatives |
| 07/13/2006 | US20060154912 Isophtalic acid derivatives |
| 07/13/2006 | CA2588627A1 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 07/12/2006 | CN1802351A Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 07/12/2006 | CN1802350A Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders |
| 07/12/2006 | CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses |
| 07/11/2006 | US7074945 Metal alkoxide taxane derivatives |
| 07/05/2006 | EP1676836A1 Regioselective hydroxylation, functionalisation and protection of spirolactams II |
| 07/05/2006 | EP1675594A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 06/29/2006 | WO2006068990A1 Process for the synthesis of azetidinones |
| 06/29/2006 | CA2591564A1 Process for the synthesis of azetidinones |
| 06/28/2006 | EP1355644B1 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 06/27/2006 | US7067675 reduction of the ketone group of 3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-alkyl- or phenyl-2-oxa- or thiazolidin-one, -thione or -alkylimine with (-)-DIP chloride to obtain the corresponding 5-hydroxy- derivative |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067305 Enzymatic process for the resolution for enantiomeric mixtures of β-lactams |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | US20060135755 Process for the synthesis of azetidinones |
| 06/22/2006 | US20060135504 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 06/22/2006 | US20060135503 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/21/2006 | EP1671650A1 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 06/21/2006 | EP1670788A1 Novel hypocholesterolemic compounds |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | CN1791592A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791395A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7063977 Enzymatic resolution of t-butyl taxane derivatives |
| 06/15/2006 | WO2006039383A3 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 06/14/2006 | EP1667966A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 06/14/2006 | CN1787817A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/13/2006 | US7060697 Immunosuppressant compounds and compositions |
| 06/08/2006 | WO2006060808A1 Ezetimibe polymorphs |
| 06/08/2006 | WO2006060225A2 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds |
| 06/08/2006 | WO2005062824A8 Anti-hypercholesterolemic compounds |
| 06/07/2006 | EP1663966A1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/07/2006 | EP1663254A2 Anti-inflamatory phosphonate conjugates |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056907 Mandelic acid derivatives and their use as thrombin inhibitors |
| 06/01/2006 | WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 05/31/2006 | EP1661900A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them |
| 05/31/2006 | EP1661881A2 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 05/31/2006 | EP1660446A2 Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones |
| 05/31/2006 | EP1660445A1 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| 05/31/2006 | CN1780816A 2-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |